Viking Therapeutics, Inc. (VKTX)

25.79 -2.18 (-7.79%) USD  |  NASDAQ  |  Nov 05, 16:00
26.00 +0.21 (+0.81%) After-Hours: 04:55
More

Viking Therapeutics SG&A Expense (TTM) : 62.40M for Sept. 30, 2026

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2013. Start Trial.
Date Value
September 30, 2026 62.40M
June 30, 2026 50.70M
March 31, 2026 48.28M
December 31, 2025 48.39M
September 30, 2025 52.36M
June 30, 2025 57.52M
March 31, 2025 53.38M
December 31, 2024 49.28M
September 30, 2024 42.81M
June 30, 2024 37.92M
March 31, 2024 37.46M
December 31, 2023 37.02M
September 30, 2023 32.34M
June 30, 2023 27.69M
March 31, 2023 21.96M
December 31, 2022 16.12M
September 30, 2022 14.68M
June 30, 2022 13.05M
March 31, 2022 11.70M
December 31, 2021 10.70M
September 30, 2021 10.26M
June 30, 2021 10.37M
March 31, 2021 10.46M
December 31, 2020 10.73M
September 30, 2020 10.94M
Date Value
June 30, 2020 10.37M
March 31, 2020 9.779M
December 31, 2019 9.128M
September 30, 2019 8.654M
June 30, 2019 8.201M
March 31, 2019 7.669M
December 31, 2018 7.121M
September 30, 2018 6.567M
June 30, 2018 6.087M
March 31, 2018 5.650M
December 31, 2017 5.329M
September 30, 2017 5.025M
June 30, 2017 4.957M
March 31, 2017 4.897M
December 31, 2016 4.847M
September 30, 2016 5.158M
June 30, 2016 5.779M
March 31, 2016 6.098M
December 31, 2015 5.030M
September 30, 2015 4.143M
June 30, 2015 2.444M
March 31, 2015 0.9312M
June 30, 2014 0.6118M
March 31, 2014 0.0978M
June 30, 2013 0.0162M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Eli Lilly & Co. 12.62B
Ironwood Pharmaceuticals, Inc. 64.55M
Compass Therapeutics, Inc. 21.62M
Structure Therapeutics, Inc. 74.01M
Amgen, Inc. 5.299B